Summary

This article presents results of the prospective, single-center Smartphone Pediatric Electrocardiogram trial [SPEAR] demonstrating that smartphone-enabled electrocardiogram (ECG) devices can produce accurate tracings of diagnostic and therapeutic quality in children in the remote setting.